Delta4 in the Spotlight

Latest News & Events

Clopidogrel in FSGS

Delta4 Identifies a Potential New Therapeutic Option for Focal Segmental Glomerulosclerosis (FSGS) using computational Hyper-C Drug Discovery Platform

Delta4, a digital drug discovery company, identified a potential therapeutic option for Focal Segmental Glomerulosclerosis (FSGS) using their Hyper-C AI …

Read More →
Delta4 CEO Kurt Herpel

Delta4 CEO Kurt Herpel Featured in Insightscare Magazine: A Vision for the Future of Drug Discovery

We are incredibly proud to share that our esteemed CEO, Kurt Herpel, has recently been profiled in Insightscare Magazine. In …

Read More →
scientist reviewing data on computer

Delta4 Announces Prof. Doron Lancet To Join Scientific Advisory Board

VIENNA, Austria, March 6th, 2023 — Delta4, a digital drug discovery company focusing on the identification of new indications for …

Read More →
Delta team

Delta4 joins the EU-funded COST action PerMediK (Personalized medicine in chronic kidney disease: improved outcome based on Big Data)

The scientific aim of PerMediK is to support the development of a path towards personalized medicine in chronic kidney disease …

Read More →
Kurt Herpel, CEO of Delta4, and Revital Rattenbach, CEO of 4P-Pharma, celebrating the signature of a partnership agreement between Delta4 and 4P-Pharma in Paris (France).

4P-Pharma And Delta4 Join Forces To Find And Develop Treatments For A Rare Autoimmune Chronic Liver Disease

Paris (France) and Vienna (Austria), 31st May 2022 – 4P-Pharma, a French clinical-stage biotechnology company, and Delta4, an Austrian digital …

Read More →
clinical trial consultation

Delta4, in preparation for the first clinical study, focused on FSGS

Focal Segmental Glomerulosclerosis (FSGS) is a devastating clinical condition with defined glomerular histopathology and yet a multifaceted pathophysiological, histological, and …

Read More →

Delta4 at BIO-EUROPE 2021

From October 25-28 Delta4 attended the (virtual) BIO-EUROPE conference, the largest partnering event in Europe dedicated to the global biotechnology …

Read More →

Delta4 Announces Dr. Hans Lehrach to Join Scientific Advisory Board

VIENNA, Austria, September 27th, 2021 — Delta4, a digital drug discovery company focusing on the identification of new indications for …

Read More →

Delta4 expands Team and tackles new indications

A Welcome to Our Newest Member Following our Financing in March 2021 and our move into new premises in July …

Read More →
office desk

Office News – July ’21

We are excited to announce that Delta4 has moved into a new office in the 8th district, close to the city …

Read More →

Alfred Steininger to Join Delta4 as CFO

We are very pleased to introduce Alfred Steininger as our new Chief Financial Officer, starting in mid-July 2021. Alfred brings …

Read More →

Press Release – April ’21

Delta4 Announces Closing of Multi-million Series A Financing Round Company to Expand Focus Beyond Renal Diseases and COVID-19 Compounds Identified …

Read More →
Photo by National Cancer Institute on

FSGS and COVID-19 programs ready for Phase II studies

We are proud to announce further progress in our current drug discovery and development programs. In late 2020, Delta4 filed …

Read More →
Photo by Scott Graham on

Delta4 files four patent applications in FSGS and COVID-19

We are very pleased to announce that Delta4 has filed four patent applications for compounds and combinations of compounds in …

Read More →

BIO-Europe 2020 Digital – Partnering Event

Global connections are more important than ever. With the same powerful one-to-one partnering and valuable content, BIO-Europe Digital continues to …

Read More →
Sachs 20th Annual Biotech

Sachs 20th Annual Biotech In Europe Forum

The 20th Annual Biotech in Europe (BEF) Forum is recognized as the leading international Stage for those interested in investing …

Read More →

World Orphan Drug Congress

With over 1,500 attendees from 50+ countries, the 2020 edition of the World Orphan Drug Congress USA was held online …

Read More →

Press Release – June 2020

Delta4 Announces Results Achieved with Drug Discovery Platform Vienna, Europe (June 2, 2020) – Delta4, a biotech company using its …

Read More →

COVID-19 – Call to Action

The global crisis caused by the SARS-Cov2 outbreak requires rapidly applicable therapeutics. Available approved drug substances represent one of the …

Read More →

Biotech Showcase 2020 @JPM San Francisco

What Is It? Biotech Showcase™ is an investor conference during JPM 2020, devoted to providing private and public biotech companies …

Read More →

LSX Investival Showcase London

Returning for its fourth year, LSX’s Investival Showcase continues and expands upon its exclusive partnership with global investment bank Jefferies, …

Read More →

Life-Science Investment Days, Vienna

Delta4 will be on-site at the Life-Science Investment Days on November 8th in Vienna. The Life Science Investment Days Contact us to make …

Read More →

Rising Stars at BEF19

Delta4 was presenting at the Biotech in Europe Investment Forum 2019 in Basel in the “Rising Stars” session – contact …

Read More →

Meet us at BEF19 in Basel

Delta4 will be presenting at the 19th Annual Biotech in Europe Forum in Basel. Contact us to make an appointment.

Read More →